Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRbg Holdings Regulatory News (RBGP)

  • This share is currently suspended. It was suspended at a price of 0.89
  • There is currently no data for RBGP

Investor Presentation

21 Jan 2022 07:00

RNS Number : 1555Z
RBG Holdings PLC
21 January 2022
 

Reach

 

21 January 2022

 

RBG Holdings plc

("the Group" or "the Company")

 

Investor Presentation

 

RBG Holdings plc (AIM: RBGP), the professional services group, is expected to publish a pre-close trading update for the twelve months ending 31 December 2021 on 27 January 2022. The Company will provide a live investor presentation via the Investor Meet Company (IMC) platform on 27 January 2022 at 10.00am.

 

Hosted by CEO, Nicola Foulston, the online presentation is open to all existing and potential shareholders. Investors can sign up to Investor Meet Company for free and add RBG Holdings plc via

https://www.investormeetcompany.com/rbg-holdings-plc/register-investor

Investors who have already registered and added to meet the Company, will be automatically invited.

Questions can be submitted pre-event via the IMC dashboard or any time during the live presentation via the "Ask a Question" function.

 

Although the Company may not be able to answer every question it receives, it will address the most prominent within the confines of information already disclosed to the market.

 

Responses to the Q&A from the live presentation will be published at the earliest opportunity on the IMC platform. Investor feedback can also be submitted directly to management post-event to ensure the Company can understand the views of all elements of its shareholder base.

 

Enquiries:

 

SECNewgate

Tel: +44 (0)7540 106366

Robin Tozer/ /Isabelle Smurfit

rbg@secnewgate.co.uk

 

About RBG Holdings plc

RBG Holdings plc is a professional services group, which comprises the following divisions:

 

RBG Legal Services Limited ("RBGLS")

RBGLS is the Company's legal services division which combines the businesses previously operated by Rosenblatt Limited and Memery Crystal Limited.

 

 

Rosenblatt

Rosenblatt is one of the UK's pioneering legal practices and a leader in dispute resolution. Rosenblatt provides a range of legal services to its diversified client base, which includes companies, banks, entrepreneurs and individuals. Complementing this is Rosenblatt's increasingly international footprint, advising on complex cross-jurisdictional disputes.

 

 

Memery Crystal

Memery Crystal offers legal services in a range of areas such as corporate (including a market-leading corporate finance offering), real estate, commercial, IP & technology (CIPT), banking & finance, tax & wealth structuring and employment. Memery Crystal is one of the leading legal practices in the UK to advise the emerging cannabis sector on a wide range of business issues. Memery Crystal offers a partner-led service to a broad range of clients, from multinational companies, financial institutions and owner-managed businesses to individual entrepreneurs.

 

LionFish Litigation Finance Limited ("LionFish")

The Company also provides litigation finance in selected cases through a separate arm, LionFish Litigation Finance Limited. LionFish finances litigation matters being run by other solicitors in return for a significant return on the outcome of those cases. As such, the Company has two types of litigation assets - Rosenblatt's own client matters, and litigation matters run by third-party solicitors. LionFish is positioned to be a unique, alternative provider to the traditional litigation funders.

 

Convex Capital Limited ("Convex Capital")

Convex Capital is a specialist sell-side corporate finance boutique based in Manchester. Convex Capital is entirely focused on helping companies, particularly owner-managed and entrepreneurial businesses, realise their value through sales to large corporates. Convex Capital identifies and proactively targets firms that it believes represent attractive acquisition opportunities.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAFZGZMNGMGZZM
Date   Source Headline
26th Jul 20234:13 pmRNSHolding(s) in Company
12th Jul 20237:00 amRNSSale of LionFish Litigation Finance Limited
27th Jun 20237:00 amRNSDirectorate Change
22nd Jun 202311:11 amRNSResult of AGM & Directorate Change
23rd May 20239:07 amRNSNotice of AGM and Dividend
17th May 20233:28 pmRNSHolding(s) in Company
26th Apr 20237:00 amRNSResults for the year ended 31 Dec 2022
18th Apr 20237:00 amRNSNotice of Investor Presentation
3rd Mar 202312:44 pmRNSCorrection: Board Changes and Notice of Results
3rd Mar 202312:18 pmRNSBoard Changes and Notice of Results
31st Jan 20237:00 amRNSBoard Changes & Pre-Close Trading Update
3rd Jan 20237:00 amRNSDirectorate Changes
12th Dec 20227:00 amRNSDirector/PDMR Shareholding
7th Dec 20227:00 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSDirector/PDMR Shareholding
5th Dec 20222:05 pmRNSSecond Price Monitoring Extn
5th Dec 20222:00 pmRNSPrice Monitoring Extension
5th Dec 202211:05 amRNSSecond Price Monitoring Extn
5th Dec 202211:00 amRNSPrice Monitoring Extension
5th Dec 20229:05 amRNSSecond Price Monitoring Extn
5th Dec 20229:00 amRNSPrice Monitoring Extension
5th Dec 20227:00 amRNSTrading & Dividend Update
13th Sep 20227:00 amRNSUnaudited Interim Results
15th Aug 20227:00 amRNSInvestor Presentation
19th Jul 202211:26 amRNSProgressive publishes new research
18th Jul 20227:00 amRNSPre-Close Trading Update
23rd Jun 202212:03 pmRNSResult of AGM
7th Jun 20225:20 pmRNSLimited Employee Share Sale to Satisfy Demand
30th May 20224:55 pmRNSAnnual Report and Accounts and Notice of AGM
1st Apr 20229:33 amRNSCorrection: Results for year ended 31 Dec 2021
1st Apr 20227:01 amRNSAudited results - year ended 31 December 2021
1st Apr 20227:00 amRNSExecutive Incentive Plan
30th Mar 20221:29 pmRNSRevised Notice of Results & Investor Presentation
25th Mar 20222:09 pmRNSRevised Notice of Results
15th Feb 20227:00 amRNS£20 million litigation investment arrangement
27th Jan 20227:00 amRNSPre-Close Trading & Dividend Update
21st Jan 20227:00 amRNSInvestor Presentation
11th Jan 20227:00 amRNSPurchase of Shares by Directors of Convex
2nd Dec 20217:00 amRNSPurchase of Shares by Directors of Convex
29th Sep 20217:00 amRNSPurchase of Shares by Directors of Convex
15th Sep 20217:00 amRNSUnaudited Interim Results
13th Sep 20218:00 amRNSPurchase of Shares by Directors of Convex
2nd Sep 20217:00 amRNSIntegration Update
16th Jul 20217:00 amRNSPre-Close Trading & Dividend Update
5th Jul 20218:03 amRNSPurchase of Shares by Directors of Convex
17th Jun 20212:39 pmRNSBoard Changes
17th Jun 20212:33 pmRNSResult of AGM
28th May 20215:18 pmRNSCompletion of acquisition
25th May 20213:56 pmRNSNotice of AGM and Shareholder Q&A
11th May 20216:09 pmRNSAnnual Report and Accounts and AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.